Keyword
Quick search:
Content Search
Result Content Research
Result Content Research
1 Mining Structured Credit for Incremental Yield, Duration Management and Diversification
2 Further Analyses Expand Upon Duration of Benefit With Sotorasib in KRAS G12C+ NSCLC
3 ODOT advisory: ODOT District 4 Multi-County Culvert Maintenance Project in Ashtabula, Mahoning, Portage, Stark, Summit and Trumbull counties
4 Ocular Therapeutix™ Announces Topline Results for Phase 2 Clinical Trial of OTX-CSI for the Treatment of Dry Eye Disease Did Not Meet Primary Endpoint
5 Shorter Sleep Duration, Smoking More Prominent in Caregivers
6 FDA Grants Fast Track Designation to Nemvaleukin Alfa Plus Pembrolizumab for Platinum-Resistant Ovarian Cancer
7 Enasidenib/Azacitidine Combination Significantly Improves ORR in AML
8 Gov. Phil Murphy declares State of Emergency for N.J. ahead of nor'easter
9 PHOMS Linked to Disease Duration, Higher Disability in Primary Progressive MS
10 Longer anti-TNF-a treatment duration links to sustained benefit
11 RET Inhibitors Show Promise for Chinese Patients With RET Fusion–Positive NSCLC
12 Imatinib May Reduce Mortality, Mechanical Ventilation Duration in COVID-19
13 Supporting Youth: New Findings in Youth Depression and Beyond
14 Teprotumumab Proves Benefit in Longer Duration Thyroid Eye Disease
15 The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study
16 Erectile Dysfunction Found as Significant Indicator for T2D Severity
17 Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
18 Antibiotic Use in the Emergency Department: A 2-Door Opportunity for Stewardship
19 Pfizer/BioNTech COVID-19 vaccine effectiveness drops after 6 months, study shows
20 Agenus Withdraws BLA for Balstilimab in Metastatic Cervical Cancer
21 The impact of on-premises piped water supply on fecal contamination pathways in rural Zambia | npj Clean Water
22 Improvements Needed Across Growth Hormone Treatment Continuum
23 Evidence for European presence in the Americas in ad 1021
24 Experimental evidence for neonicotinoid driven decline in aquatic emerging insects
25 Global mapping of crop-specific emission factors highlights hotspots of nitrous oxide mitigation
26 An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in Vietnam
27 Assessment of plum rain's impact on power system emissions in Yangtze-Huaihe River basin of China
28 Influence of air pollutants on varicella among adults | Scientific Reports
29 Upslope migration of snow avalanches in a warming climate
30 Optogenetic stimulation of glutamatergic neurons in the cuneiform nucleus controls locomotion in a mouse model of Parkinson's disease
31 Tremeau Expands Pipeline with Novel Non-Opioid Compound for the Treatment of Acute Pain
32 Peptides: a promising alternative to opioids for chronic pain relief
33 Regulation of prefrontal patterning and connectivity by retinoic acid
34 Geophysical constraints on the reliability of solar and wind power worldwide
35 Neural oscillatory activity serving sensorimotor control is predicted by superoxide-sensitive mitochondrial redox environments
36 Probiotic consumption influences universal adaptive mutations in indigenous human and mouse gut microbiota | Communications Biology
37 Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19
38 Longer Diabetes Duration Associated with Higher Risk of Tuberculosis Incidence
39 Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
40 No Difference in Survival Noted With Longer Duration of Bevacizumab for Ovarian Cancer
41 Staff Workshop on Proposed Development for Long Duration Energy Storage Scenarios
42 ImmunityBio Announces Positive Durable Responses in BCG Unresponsive Bladder Cancer Patients with a Complete Response Rate of 72%, Median Duration of Complete Response of 19.9 Months, and 85% Remaining Cystectomy-free in Phase 2/3 Trial
43 Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 | NEJM
44 Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
45 Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
46 Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
47 Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2
48 Over 1‐year duration and age difference of SARS‐CoV‐2 antibodies in convalescent COVID‐19 patients
49 A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States
50 Therapeutic Application of Corticosteroids in COVID‐19: A Focus on Optimum Dose and Duration of Therapy
51 Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 | NEJM
52 Subjective Social Status and Short Sleep Duration
53 Final Results from the Longest Hereditary Angioedema Study of Active Treatment Duration Conducted to Date Support the Sustained Safety and Efficacy of TAKHZYRO® (lanadelumab) Injection for Long-Term Prevention of Hereditary Angioedema Attacks
54 IMBRUVICA® (ibrutinib)-Based Combination Regimen as a Fixed-Duration, First-Line Treatment for Chronic Lymphocytic Leukaemia Demonstrates High Rates of Disease Control
55 Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia | NEJM
56 Rybrevant-Leclaza combo improves response rate, duration in NSCLC
57 Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
58 Ruxolitinib in GVHD Reveals Lower Risk of Relapse, Longer Duration of Response
59 Data From the CAPTIVATE Study's uMRD Cohort Suggest Role for Fixed-Duration Therapy in CLL/SLL [Q&A]
60 Novan's Stock Surges As SB206 Can Potentially Shorten Duration Of Contagious Skin Disease
61 Fixed-duration ibrutinib-venetoclax induces deep responses in treatment-naive CLL
62 Association of sleep duration with all-cause mortality in East Asian adults
63 Evolution of antibody immunity to SARS-CoV-2
64 Long-term Follow-up Solidifies Role of Fixed-duration Venetoclax Plus Rituximab in Relapsed/Refractory CLL
65 11 long-term side effects of chemotherapy: Duration and more
66 COVID vaccine immunity is waning — how much does that matter?
67 SARS-CoV-2 Antibody Response in Persons with Past Natural Infection | NEJM
68 Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia | NEJM
69 DHS withdraws Duration of Status rule proposal
70 Diabetes and Tuberculosis Link Quantified | MedPage Today
71 Supervisor Preston wants free Muni for duration of pandemic
72 Seizure likelihood varies with day-to-day variations in sleep duration in patients with refractory focal epilepsy: A longitudinal electroencephalography investigation
73 Implied Equity Duration: A Measure of Pandemic Shutdown Risk
74 Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
75 Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study
76 First look at the 2024 total solar eclipse
77 Macaulay Duration vs. Modified Duration: What's the Difference?
78 Define 'a While': How Long Will a Bipolar Manic Episode Last?
79 Interim statement on COVID-19 vaccine booster doses
80 Six Important Things to Know About Breakthrough Infections
81 Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
82 Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
83 Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma | NEJM
84 Saweetie Meal arrives at McDonald's Monday for a limited time with a new ‘Saweetstakes’ contest
85 Nuveen Short Duration Credit Opportunities Fund (JSD) Ex-Dividend Date Scheduled for October 14, 2021
86 Anthropogenic climate change is worsening North American pollen seasons
87 PGIM Short Duration High Yield Opportunities Fund Reports Unaudited Earnings and Financial Position for Period Ended January 31, 2021
88 Effectiveness of mRNA Covid-19 Vaccine among US Health Care Personnel
89 Doctor, How Long Should I Isolate? | NEJM
90 Genshin Impact Thoma banner and abilities
91 Viable SARS-CoV-2 Shedding | NEJM
92 New Data Shows AbbVie's VENCLYXTO®/VENCLEXTA® Fixed Duration Combination Demonstrates Sustained Progression-Free Survival in Chronic Lymphocytic Leukemia Patients after Three Years off Treatment
93 Corticosteroids for COVID-19: the search for an optimum duration of therapy
94 Resumption of Cardiac Activity after Withdrawal of Life-Sustaining Measures | NEJM
95 New Phase 3 Study Results Show IMBRUVICA® (ibrutinib)-Based Combination Regimen as an All-Oral Fixed-Duration Treatment Demonstrated Superior Progression-Free Survival in Adult Patients with Previously Untreated Chronic Lymphocytic Leukaemia
96 Sleep duration and snoring at midlife | NSS
97 Short Sleep Duration Among Nurses | RMHP
98 SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
99 Genshin Impact Klee banner release date
100 Prolonged Duration of Response With Tivozanib for RCC Revealed at Long-Term Follow-Up